Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
Hinz M, Stein A, Neff R,Weinberg R, Uncini T. Neuropsych Dis Treat. 2011;7:31–38. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the...
Guardado en:
Autores principales: | Hinz M, Stein A, Neff R, Weinberg R, Uncini T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f86369b6bc254695b13742acd6aa9157 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Retraction]
por: Hinz M, et al.
Publicado: (2020) -
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
por: Marty Hinz, et al.
Publicado: (2011) -
5-HTP Efficacy and Contraindications [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020) -
5-HTP Efficacy and Contraindications [Retraction]
por: Hinz M, et al.
Publicado: (2021) -
The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)